Correlation Between TG Therapeutics and Halozyme Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Halozyme Therapeutics, you can compare the effects of market volatilities on TG Therapeutics and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Halozyme Therapeutics.

Diversification Opportunities for TG Therapeutics and Halozyme Therapeutics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between TGTX and Halozyme is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Halozyme Therapeutics go up and down completely randomly.

Pair Corralation between TG Therapeutics and Halozyme Therapeutics

Given the investment horizon of 90 days TG Therapeutics is expected to generate 1.04 times more return on investment than Halozyme Therapeutics. However, TG Therapeutics is 1.04 times more volatile than Halozyme Therapeutics. It trades about 0.32 of its potential returns per unit of risk. Halozyme Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  2,435  in TG Therapeutics on August 28, 2024 and sell it today you would earn a total of  1,026  from holding TG Therapeutics or generate 42.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

TG Therapeutics  vs.  Halozyme Therapeutics

 Performance 
       Timeline  
TG Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Halozyme Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Halozyme Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

TG Therapeutics and Halozyme Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TG Therapeutics and Halozyme Therapeutics

The main advantage of trading using opposite TG Therapeutics and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.
The idea behind TG Therapeutics and Halozyme Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments